Literature DB >> 231642

1-aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent.

L C Washburn, T T Sun, B Byrd, R L Hayes, T A Butler.   

Abstract

1-Aminocyclobutane[14C]carboxylic acid [C-14) ACBC] was incorporated preferentially by several tumor types in rats and hamsters. The agent was cleared rapidly from rat blood, attaining its maximum tissue concentrations within 30 min after i.v. injection. Carrier ACBC had little effect on the tissue distribution of (C-14) ACBC. This agent showed no affinity for a Staphylococcus aureus abscess in rats. The total excretion was low, 3.6% in 2 hr. (C-11) ACBC was synthesized in amounts up to 415 mCi (55% chemical yield) using our modified Bücherer-Strecker technique. Forty minutes were required for the two-step synthesis and chromatographic purification. ACBC was found to be nontoxic in three animal species. The radiation dose from (C-11) ACBC should be minimal. (C-11) ACBC thus appears to have good potential as a tumor-seeking agent, particularly when used with a positron emission computed tomograph.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231642

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.

Authors:  Bital Savir-Baruch; David M Schuster; Nashwa Jarkas; Viraj A Master; Peter T Nieh; Raghuveer K Halkar; Jonathon A Nye; Melinda M Lewis; Ronald J Crowe; Ronald J Voll; Vernon M Camp; Leah M Bellamy; David L Roberts; Mark M Goodman
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 2.  PET Tracers Beyond FDG in Prostate Cancer.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti
Journal:  Semin Nucl Med       Date:  2016-09-07       Impact factor: 4.446

3.  [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.

Authors:  Cristina Nanni; Lucia Zanoni; Tore Bach-Gansmo; Heikki Minn; Frode Willoch; Trond Velde Bogsrud; Ephraim Parent Edward; Bital Savir-Baruch; Eugene Teoh; Fenton Ingram; Stefano Fanti; David M Schuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-11       Impact factor: 9.236

4.  Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti; Shuntaro Oka; Hiroyuki Okudaira; Yusuke Inoue; Jens Sörensen; Rikard Owenius; Peter Choyke; Baris Turkbey; Trond V Bogsrud; Tore Bach-Gansmo; Raghuveer K Halkar; Jonathon A Nye; Oluwaseun A Odewole; Bital Savir-Baruch; Mark M Goodman
Journal:  J Nucl Med       Date:  2014-11-13       Impact factor: 10.057

Review 5.  The next generation of positron emission tomography radiopharmaceuticals in oncology.

Authors:  Samuel L Rice; Celeste A Roney; Pierre Daumar; Jason S Lewis
Journal:  Semin Nucl Med       Date:  2011-07       Impact factor: 4.446

6.  Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.

Authors:  Gen Futamura; Shinji Kawabata; Naosuke Nonoguchi; Ryo Hiramatsu; Taichiro Toho; Hiroki Tanaka; Shin-Ichiro Masunaga; Yoshihide Hattori; Mitsunori Kirihata; Koji Ono; Toshihiko Kuroiwa; Shin-Ichi Miyatake
Journal:  Radiat Oncol       Date:  2017-01-23       Impact factor: 3.481

7.  Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents.

Authors:  Thomas C Pickel; Gouthami Pashikanti; Ronald J Voll; Weiping Yu; Zhaobin Zhang; Jonathon A Nye; John Bacsa; Jeffrey J Olson; Lanny S Liebeskind; Mark M Goodman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.